# A Trial of MitoQ for the Treatment of People With Parkinson's Disease

> **NCT00329056** · PHASE2 · COMPLETED · sponsor: **Antipodean Pharmaceuticals, Inc.** · enrollment: 128 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** MitoQ

## Key facts

- **NCT ID:** NCT00329056
- **Lead sponsor:** Antipodean Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2010-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329056, "A Trial of MitoQ for the Treatment of People With Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00329056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*